These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 16150062

  • 21. Rotavirus vaccines in developed countries.
    Buttery JP, Kirkwood C.
    Curr Opin Infect Dis; 2007 Jun; 20(3):253-8. PubMed ID: 17471034
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Characteristics of an ideal rotavirus vaccine.
    Reisinger KS, Block SL.
    Clin Pediatr (Phila); 2008 Jul; 47(6):555-63. PubMed ID: 18467670
    [Abstract] [Full Text] [Related]

  • 24. Rotavirus vaccines: entering a new stage of deployment.
    Nakagomi O, Cunliffe NA.
    Curr Opin Infect Dis; 2007 Oct; 20(5):501-7. PubMed ID: 17762784
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Potential intussusception risk versus health benefits from rotavirus vaccination in Latin America.
    Desai R, Parashar UD, Lopman B, de Oliveira LH, Clark AD, Sanderson CF, Tate JE, Matus CR, Andrus JK, Patel MM.
    Clin Infect Dis; 2012 May; 54(10):1397-405. PubMed ID: 22431803
    [Abstract] [Full Text] [Related]

  • 27. More on RotaShield and intussusception: the role of age at the time of vaccination.
    Simonsen L, Viboud C, Elixhauser A, Taylor RJ, Kapikian AZ.
    J Infect Dis; 2005 Sep 01; 192 Suppl 1():S36-43. PubMed ID: 16088803
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Reduction in rotavirus after vaccine introduction--United States, 2000-2009.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2009 Oct 23; 58(41):1146-9. PubMed ID: 19847149
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. A hexavalent human rotavirus-bovine rotavirus (UK) reassortant vaccine designed for use in developing countries and delivered in a schedule with the potential to eliminate the risk of intussusception.
    Kapikian AZ, Simonsen L, Vesikari T, Hoshino Y, Morens DM, Chanock RM, La Montagne JR, Murphy BR.
    J Infect Dis; 2005 Sep 01; 192 Suppl 1():S22-9. PubMed ID: 16088801
    [Abstract] [Full Text] [Related]

  • 33. The human rotavirus vaccine RIX4414 in infants: a review of safety and tolerability.
    Cheuvart B, Friedland LR, Abu-Elyazeed R, Han HH, Guerra Y, Verstraeten T.
    Pediatr Infect Dis J; 2009 Mar 01; 28(3):225-32. PubMed ID: 19209095
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.